Scientific Due Diligence

Scientific Due Diligence Services for Biotech and Pharma Investments

At ecSeq Bioinformatics, we support pharmaceutical and biotech companies and their investors with scientific due diligence to make well-informed, data-driven decisions. Our services include NGS data validation, bioinformatics pipeline review, and scientific claim verification, ensuring that your potential investments are based on reliable scientific foundations.

Comprehensive Scientific Due Diligence Services

• Technology and Methodology Evaluation
  Our team critically analyzes NGS technologies, methodologies, and workflows. We verify their validity, documentation, and alignment with current bioinformatics and genomics standards to ensure state-of-the-art performance.

• Pipeline and Workflow Validation
  We conduct rigorous NGS pipeline and software architecture evaluations, assessing robustness, reproducibility, and compliance with industry benchmarks to validate scientific integrity.

• Data Integrity and Reproducibility Checks
  Our experts check data quality and processing standards, identifying any inconsistencies or gaps that might impact the project’s reliability and your decision-making.

• Scientific Claim Validation
  We verify scientific statements against available data and industry standards, providing independent, evidence-based insights that help confirm or challenge project claims.

• Risk Assessment and Mitigation Strategies
  Our due diligence includes a comprehensive risk analysis, identifying scientific, technical, and operational factors that could affect success, along with actionable recommendations to mitigate risks.

Unmatched Bioinformatics Expertise and Extensive Network

With over a decade of experience in Next-Generation Sequencing (NGS) and bioinformatics, ecSeq Bioinformatics offers unmatched expertise in scientific due diligence. Our vast network includes leading scientists in genomics, molecular biology, immunology, statistics, software development, and more. Through this network, we provide comprehensive, on-demand consultations to ensure field-specific expert insights across all relevant areas.

Independent Reporting for Investors and Key Decision-Makers

Our structured due diligence process starts with understanding your specific goals. We create customized reports for various audiences, including investors, business development teams, and C-level executives, delivering independently verified results that are clear, actionable, and ready for strategic decisions. These reports are tailored to inform stakeholders of the technical viability and scientific credibility of potential investments.

With a strong track record of supporting leading life sciences companies, ecSeq Bioinformatics is a trusted partner in scientific due diligence, providing expert-backed evaluations that guide strategic investments and business development.